NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
0.3096
-0.0405 (-11.57%)
Apr 28, 2025, 4:00 PM EDT - Market closed

NewGenIvf Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.435.145.944.12
Revenue Growth (YoY)
5.79%-13.59%44.34%-
Cost of Revenue
3.613.454.413.09
Gross Profit
1.831.681.541.02
Selling, General & Admin
2.991.641.140.83
Operating Expenses
2.991.641.140.83
Operating Income
-1.160.040.40.2
Interest Expense
-0.78-0.05-0.08-0.09
Interest & Investment Income
0.01000
Other Non Operating Income (Expenses)
0.970.110.020.05
Pretax Income
-0.960.110.340.16
Income Tax Expense
-0.49-0.210.29
Earnings From Continuing Operations
-0.470.110.14-0.14
Minority Interest in Earnings
-0.050.020.320.14
Net Income
-0.520.130.46-0
Net Income to Common
-0.520.130.46-0
Net Income Growth
--71.61%--
Shares Outstanding (Basic)
0000
Shares Outstanding (Diluted)
0000
Shares Change (YoY)
1064.31%6.81%2.85%-
EPS (Basic)
-1.474.2315.93-0.02
EPS (Diluted)
-1.474.2315.93-0.02
EPS Growth
--73.42%--
Free Cash Flow
-8.32-1.841.621.42
Free Cash Flow Per Share
-23.23-59.6956.1350.59
Gross Margin
33.62%32.74%25.87%24.88%
Operating Margin
-21.36%0.82%6.71%4.83%
Profit Margin
-9.66%2.54%7.72%-0.01%
Free Cash Flow Margin
-153.08%-35.75%27.19%34.39%
EBITDA
-1.140.070.50.37
EBITDA Margin
-21.00%1.43%8.40%8.88%
D&A For EBITDA
0.020.030.10.17
EBIT
-1.160.040.40.2
EBIT Margin
-21.36%0.82%6.71%4.83%
Effective Tax Rate
--60.51%188.70%
Updated Dec 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q